AHA ACLS Provider Final Actual Exam Prep Document |
2026/2027 Edition | 250 Verified Questions
AHA ACLS Provider Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest AHA Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for healthcare professionals
and Advanced Cardiovascular Life Support (ACLS) candidates preparing for the American Heart
Association (AHA) ACLS Provider Final Exam. It contains 250 verified questions that reflect the most
current AHA guidelines, ensuring alignment with the 2026/2027 academic year. Each question is
accompanied by a correct answer and a detailed rationale, facilitating a deep understanding of critical
concepts. This resource is an essential tool for achieving certification and mastering the skills required
for effective resuscitation in clinical settings.
Key Features:
High-quality CPR and AED usage
Airway management and ventilation techniques
Recognition and treatment of cardiac arrest rhythms
Pharmacology: vasopressors, antiarrhythmics, and other ACLS drugs
Post-cardiac arrest care and team dynamics
Acute coronary syndromes and stroke management
Updates for 2026:
- Updated to reflect the latest AHA guidelines for CPR and ECC
- Incorporates 2026/2027 academic year changes and exam format
- Includes new questions on emerging resuscitation science
- Enhanced rationales with evidence-based explanations
- Revised to emphasize team-based resuscitation and communication
Abstract:
The AHA ACLS Provider Final Exam is a rigorous assessment of a clinician's ability to manage cardiac
emergencies, including cardiac arrest, acute coronary syndromes, and stroke. This exam prep document offers 250
verified questions that cover the full spectrum of ACLS algorithms, from basic life support to advanced airway
management and pharmacological interventions. Each question is crafted to test critical thinking and clinical
decision-making, with rationales that explain the 'why' behind each correct answer. The content is organized by
core areas, allowing for targeted study and self-assessment. By engaging with this material, candidates will
reinforce their knowledge of high-quality CPR, rhythm recognition, defibrillation, and post-resuscitation care. This
resource is an indispensable aid for passing the final exam and, more importantly, for providing optimal care in
real-life resuscitation scenarios.
Keywords:
ACLS Provider, AHA guidelines, Cardiac arrest, Resuscitation, CPR, Defibrillation, Post-cardiac arrest care,
Emergency pharmacology
Answer Format:
Each question is presented in a multiple-choice format, followed by the correct answer and a comprehensive
rationale. The rationale explains the underlying physiology, guideline recommendations, and clinical reasoning,
helping candidates understand not just what is correct but why. Distractor explanations are provided to clarify
common misconceptions and reinforce learning.
Compliance Checklist:
Page 1
, Aligned with the latest AHA Guidelines for CPR and ECC
Verified by experienced ACLS instructors and clinicians
Updated for the 2026/2027 academic year
Covers all core ACLS algorithms and scenarios
Includes rationales for every answer to enhance understanding
Suitable for both initial certification and recertification
Content Area Overview:
Content Area Questions Key Topics Weight
Basic Life Support (BLS) and 1-40 Chest compressions, ventilation, AED use, 16%
High-Quality CPR team dynamics
Airway Management and 41-70 Bag-mask ventilation, advanced airways, 12%
Ventilation capnography
Cardiac Arrest Rhythms and 71-120 VF/pVT, asystole, PEA, ACLS algorithms 20%
Algorithms
Pharmacology in ACLS 121-160 Epinephrine, amiodarone, lidocaine, 16%
atropine, magnesium
Acute Coronary Syndromes 161-190 STEMI, NSTEMI, unstable angina, 12%
(ACS) reperfusion strategies
Stroke Management 191-210 Stroke recognition, tPA, acute interventions 8%
Post-Cardiac Arrest Care 211-230 ROSC, targeted temperature management, 8%
hemodynamic optimization
Team Dynamics and 231-250 Leadership, roles, closed-loop 8%
Communication communication, debriefing
Page 2
,Q1. During a resuscitation, the team leader orders epinephrine 1 mg IV push. The
medication is drawn up from a 10 mL vial labeled 'Epinephrine 1 mg/10 mL'. What is
the correct dose and route?
A. Administer the entire 10 mL IV push
B. Administer 1 mL IV push, then flush with 20 mL
C. Administer 5 mL IV push, then flush with 10 mL
D. Administer 10 mL IV push, then flush with 20 mL
Correct Answer: A. Administer the entire 10 mL IV push
Rationale: The vial contains 1 mg in 10 mL, so the entire 10 mL provides the correct 1 mg
dose. Standard practice is to give the full volume of the prefilled syringe or vial, then a 20
mL flush to promote central delivery. Options B and C underdose, and D is correct but the
flush is extra, though not harmful.
Why Wrong:
B - This delivers only 0.1 mg, a subtherapeutic dose.
C - This delivers 0.5 mg, insufficient for cardiac arrest.
D - This delivers the correct dose but the flush is not standard; however, the dose is
correct, so this is not the best answer.
Reference: AHA ACLS Provider Manual, 2020 Guidelines, Pharmacology section
Q2. A patient with suspected acute coronary syndrome has a 12-lead ECG showing
ST-segment elevation in leads II, III, and aVF. Which intervention is most
appropriate if the patient has no contraindications?
A. Administer sublingual nitroglycerin and reassess pain
B. Initiate fibrinolytic therapy immediately
C. Prepare for emergent coronary angiography
D. Start aspirin and heparin only
Correct Answer: C. Prepare for emergent coronary angiography
Rationale: ST-elevation in inferior leads indicates an acute STEMI. The preferred
reperfusion strategy is primary PCI if available within 120 minutes of first medical
contact. Fibrinolysis is an alternative only if PCI is not available. Nitroglycerin and
aspirin are adjuncts, not definitive reperfusion.
Why Wrong:
A - Nitroglycerin relieves symptoms but does not restore coronary blood flow.
B - Fibrinolysis is reserved for when PCI is not available within 120 minutes.
D - Aspirin and heparin are important but do not achieve reperfusion.
Reference: AHA ACLS Provider Manual, Acute Coronary Syndromes algorithm
Page 3
, Q3. A patient in cardiac arrest has a rhythm of pulseless electrical activity (PEA).
Which of the following is a potentially reversible cause that should be considered and
treated immediately?
A. Hyperkalemia
B. Ventricular tachycardia
C. Atrial fibrillation
D. Sinus bradycardia
Correct Answer: A. Hyperkalemia
Rationale: PEA is often caused by reversible conditions such as hypovolemia, hypoxia,
tamponade, tension pneumothorax, and metabolic disturbances like hyperkalemia.
Ventricular tachycardia and atrial fibrillation are arrhythmias, not causes of PEA. Sinus
bradycardia is a rhythm, not a cause.
Why Wrong:
B - Ventricular tachycardia is a shockable rhythm, not a cause of PEA.
C - Atrial fibrillation is a supraventricular arrhythmia, not a cause of PEA.
D - Sinus bradycardia is a rhythm, not a cause of PEA.
Reference: AHA ACLS Provider Manual, H's and T's
Q4. Which of the following best describes the recommended
compression-to-ventilation ratio for a single rescuer providing CPR to an adult
victim?
A. 15:2 with a pause for ventilations
B. 30:2 with asynchronous ventilations
C. 30:2 with a pause for ventilations
D. 15:2 with asynchronous ventilations
Correct Answer: C. 30:2 with a pause for ventilations
Rationale: For a single rescuer, the AHA recommends a ratio of 30:2, with pauses for
ventilations. Asynchronous ventilations are used in advanced airway management with
continuous compressions. The 15:2 ratio is for pediatric two-rescuer CPR.
Why Wrong:
A - 15:2 is not the adult single-rescuer ratio.
B - Asynchronous ventilations are not used without an advanced airway.
D - 15:2 is for pediatric, and asynchronous is not appropriate for single rescuer.
Reference: AHA CPR Guidelines, Adult Basic Life Support
Q5. A patient presents with symptomatic bradycardia (heart rate 40 bpm) and
hypotension. After ensuring airway and breathing, what is the first-line
pharmacological intervention?
Page 4
2026/2027 Edition | 250 Verified Questions
AHA ACLS Provider Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest AHA Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for healthcare professionals
and Advanced Cardiovascular Life Support (ACLS) candidates preparing for the American Heart
Association (AHA) ACLS Provider Final Exam. It contains 250 verified questions that reflect the most
current AHA guidelines, ensuring alignment with the 2026/2027 academic year. Each question is
accompanied by a correct answer and a detailed rationale, facilitating a deep understanding of critical
concepts. This resource is an essential tool for achieving certification and mastering the skills required
for effective resuscitation in clinical settings.
Key Features:
High-quality CPR and AED usage
Airway management and ventilation techniques
Recognition and treatment of cardiac arrest rhythms
Pharmacology: vasopressors, antiarrhythmics, and other ACLS drugs
Post-cardiac arrest care and team dynamics
Acute coronary syndromes and stroke management
Updates for 2026:
- Updated to reflect the latest AHA guidelines for CPR and ECC
- Incorporates 2026/2027 academic year changes and exam format
- Includes new questions on emerging resuscitation science
- Enhanced rationales with evidence-based explanations
- Revised to emphasize team-based resuscitation and communication
Abstract:
The AHA ACLS Provider Final Exam is a rigorous assessment of a clinician's ability to manage cardiac
emergencies, including cardiac arrest, acute coronary syndromes, and stroke. This exam prep document offers 250
verified questions that cover the full spectrum of ACLS algorithms, from basic life support to advanced airway
management and pharmacological interventions. Each question is crafted to test critical thinking and clinical
decision-making, with rationales that explain the 'why' behind each correct answer. The content is organized by
core areas, allowing for targeted study and self-assessment. By engaging with this material, candidates will
reinforce their knowledge of high-quality CPR, rhythm recognition, defibrillation, and post-resuscitation care. This
resource is an indispensable aid for passing the final exam and, more importantly, for providing optimal care in
real-life resuscitation scenarios.
Keywords:
ACLS Provider, AHA guidelines, Cardiac arrest, Resuscitation, CPR, Defibrillation, Post-cardiac arrest care,
Emergency pharmacology
Answer Format:
Each question is presented in a multiple-choice format, followed by the correct answer and a comprehensive
rationale. The rationale explains the underlying physiology, guideline recommendations, and clinical reasoning,
helping candidates understand not just what is correct but why. Distractor explanations are provided to clarify
common misconceptions and reinforce learning.
Compliance Checklist:
Page 1
, Aligned with the latest AHA Guidelines for CPR and ECC
Verified by experienced ACLS instructors and clinicians
Updated for the 2026/2027 academic year
Covers all core ACLS algorithms and scenarios
Includes rationales for every answer to enhance understanding
Suitable for both initial certification and recertification
Content Area Overview:
Content Area Questions Key Topics Weight
Basic Life Support (BLS) and 1-40 Chest compressions, ventilation, AED use, 16%
High-Quality CPR team dynamics
Airway Management and 41-70 Bag-mask ventilation, advanced airways, 12%
Ventilation capnography
Cardiac Arrest Rhythms and 71-120 VF/pVT, asystole, PEA, ACLS algorithms 20%
Algorithms
Pharmacology in ACLS 121-160 Epinephrine, amiodarone, lidocaine, 16%
atropine, magnesium
Acute Coronary Syndromes 161-190 STEMI, NSTEMI, unstable angina, 12%
(ACS) reperfusion strategies
Stroke Management 191-210 Stroke recognition, tPA, acute interventions 8%
Post-Cardiac Arrest Care 211-230 ROSC, targeted temperature management, 8%
hemodynamic optimization
Team Dynamics and 231-250 Leadership, roles, closed-loop 8%
Communication communication, debriefing
Page 2
,Q1. During a resuscitation, the team leader orders epinephrine 1 mg IV push. The
medication is drawn up from a 10 mL vial labeled 'Epinephrine 1 mg/10 mL'. What is
the correct dose and route?
A. Administer the entire 10 mL IV push
B. Administer 1 mL IV push, then flush with 20 mL
C. Administer 5 mL IV push, then flush with 10 mL
D. Administer 10 mL IV push, then flush with 20 mL
Correct Answer: A. Administer the entire 10 mL IV push
Rationale: The vial contains 1 mg in 10 mL, so the entire 10 mL provides the correct 1 mg
dose. Standard practice is to give the full volume of the prefilled syringe or vial, then a 20
mL flush to promote central delivery. Options B and C underdose, and D is correct but the
flush is extra, though not harmful.
Why Wrong:
B - This delivers only 0.1 mg, a subtherapeutic dose.
C - This delivers 0.5 mg, insufficient for cardiac arrest.
D - This delivers the correct dose but the flush is not standard; however, the dose is
correct, so this is not the best answer.
Reference: AHA ACLS Provider Manual, 2020 Guidelines, Pharmacology section
Q2. A patient with suspected acute coronary syndrome has a 12-lead ECG showing
ST-segment elevation in leads II, III, and aVF. Which intervention is most
appropriate if the patient has no contraindications?
A. Administer sublingual nitroglycerin and reassess pain
B. Initiate fibrinolytic therapy immediately
C. Prepare for emergent coronary angiography
D. Start aspirin and heparin only
Correct Answer: C. Prepare for emergent coronary angiography
Rationale: ST-elevation in inferior leads indicates an acute STEMI. The preferred
reperfusion strategy is primary PCI if available within 120 minutes of first medical
contact. Fibrinolysis is an alternative only if PCI is not available. Nitroglycerin and
aspirin are adjuncts, not definitive reperfusion.
Why Wrong:
A - Nitroglycerin relieves symptoms but does not restore coronary blood flow.
B - Fibrinolysis is reserved for when PCI is not available within 120 minutes.
D - Aspirin and heparin are important but do not achieve reperfusion.
Reference: AHA ACLS Provider Manual, Acute Coronary Syndromes algorithm
Page 3
, Q3. A patient in cardiac arrest has a rhythm of pulseless electrical activity (PEA).
Which of the following is a potentially reversible cause that should be considered and
treated immediately?
A. Hyperkalemia
B. Ventricular tachycardia
C. Atrial fibrillation
D. Sinus bradycardia
Correct Answer: A. Hyperkalemia
Rationale: PEA is often caused by reversible conditions such as hypovolemia, hypoxia,
tamponade, tension pneumothorax, and metabolic disturbances like hyperkalemia.
Ventricular tachycardia and atrial fibrillation are arrhythmias, not causes of PEA. Sinus
bradycardia is a rhythm, not a cause.
Why Wrong:
B - Ventricular tachycardia is a shockable rhythm, not a cause of PEA.
C - Atrial fibrillation is a supraventricular arrhythmia, not a cause of PEA.
D - Sinus bradycardia is a rhythm, not a cause of PEA.
Reference: AHA ACLS Provider Manual, H's and T's
Q4. Which of the following best describes the recommended
compression-to-ventilation ratio for a single rescuer providing CPR to an adult
victim?
A. 15:2 with a pause for ventilations
B. 30:2 with asynchronous ventilations
C. 30:2 with a pause for ventilations
D. 15:2 with asynchronous ventilations
Correct Answer: C. 30:2 with a pause for ventilations
Rationale: For a single rescuer, the AHA recommends a ratio of 30:2, with pauses for
ventilations. Asynchronous ventilations are used in advanced airway management with
continuous compressions. The 15:2 ratio is for pediatric two-rescuer CPR.
Why Wrong:
A - 15:2 is not the adult single-rescuer ratio.
B - Asynchronous ventilations are not used without an advanced airway.
D - 15:2 is for pediatric, and asynchronous is not appropriate for single rescuer.
Reference: AHA CPR Guidelines, Adult Basic Life Support
Q5. A patient presents with symptomatic bradycardia (heart rate 40 bpm) and
hypotension. After ensuring airway and breathing, what is the first-line
pharmacological intervention?
Page 4
